Consultation report, Dr. Ester Tahover
Oncology Department, Assuta Ramat HaHayal
HaBarzel St 20, Tel Aviv
Tel.: 03-7645177
Fax: 03-7645119
Email: cimo@assuta.co.il
“Confidential Health Information”: The information contained herein is protected by privacy laws. Disclosure of this information is a violation of the law.
27/03/2024
Conclusion of the examination – oncology department
ID No: ME923960-9 Name: Anastasia Zherlitsyna Date of birth: 25/04/1976 |
Age: 47 Address: HaBarzel St 20, Tel Aviv-Jaffa Mobile: 03-7645177 |
|---|
Clinical diagnosis:
| Diagnosis | Code | Side | Date | Condition after | Probable diagnosis | Relapse |
|---|---|---|---|---|---|---|
| Gastrointestinal stromal tumor | Н89363 |
| Discussion and conclusion: |
|---|
Registered: Dr. Esther Tachover, Medical License No.: 80855, Oncology Department, Ramat HaHayal
Update date: 27/03/2024 17:33
Report / discussion:
Consultation was provided to Egor, the patient’s brother, via Zoom.
Continues to take Imatinib. Complains of pain in the joints and stomach.
Revision of a tumor in the abdominal cavity, near the stomach, and liver: both are GIST.
PET from 08/2023: good answer.
PET from 03/2024: the disease is stable, only minimal accumulation of contrast. CBC and biochemical blood test: within normal limits.
Recommendations:
Continue taking Imatinib at the same dose.
PET – every 3 months.
A repeat biopsy should be considered if and when the tumor progresses for genomic testing.
Consider taking Pramin/Zofran for nausea, PPI for abdominal pain (eg, Omeprazole), NSAID for muscle pain (eg, Ibuprofen).
Further observation with blood tests, TSH testing and monitoring of blood pressure readings.